title: Re: Adverse Pathology and Undetectable Ultrasensitive Prostate-Specific Antigen after Radical Prostatectomy: Is Adjuvant Radiation Warranted?
authors.forename: Samir S
authors.initials: SS
authors.lastname: Taneja
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D015331:Cohort Studies; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D060787:Neoplasm Grading; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000097:blood*; D011467:Prostate / Q000473:pathology*; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy / Q000379:methods*; D011471:Prostatic Neoplasms / Q000473:pathology* / Q000628:therapy*; D018714:Radiotherapy, Adjuvant; D018570:Risk Assessment; D012669:Seminal Vesicles / Q000473:pathology; D012680:Sensitivity and Specificity
chemical_list: D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen